Friday, 15 Dec 2017

You are here

Dr. Rachel Tate: Adalimumab and Disease Remission in non-Radiographic Axial SpA

Dr. Rachel Tate discusses the ABILITY 3 study at the ACR/ARHP Annual Meeting in San Diego.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
ACR VIDEO

8 September 2017: The RheumNow Week in...

07 Sep 2017

Dr. Cush Heads to San Francisco

06 Nov 2015

Dr. Nayef Al Ghanim: RheumNow and RWCS

14 Nov 2016

RWCS 2017: Hydralazine-Induced ANCA-...

21 Feb 2017

RheumNow Week in Review – 14 October...

14 Oct 2016

EULAR 2016 Round-Up - Dr. Jack Cush

19 Jun 2016

Christopher Ritchlin, MD: exciting data...

12 Nov 2015

Dr. Cassie Calabrese: Rheumatic immune-...

02 Dec 2016

Dr. Janet Pope - Can you Stop DMARDs in...

23 Jun 2017

RheumNow Week in Review - 19 May 2016

20 May 2016

Jack Cush, MD: Safety Perspective on...

13 Nov 2015

Dr. Arthur Kavanaugh: Rheumatology...

07 Nov 2017